References
- Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–42.
- Rosselli M, Keller PJ, Dubey RK. Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum Reprod Update. 1998;4:3–24.
- Chiou GC. Review: effects of nitric oxide on eye diseases and their treatment. J Ocul Pharmacol Ther. 2001;17(2):189–98. doi:https://doi.org/10.1089/10807680151125555.
- Drago F, Bucolo C. Therapeutic potential of nitric oxide modulation in ocular diseases. Drug News Perspect. 2010;23(7):430–37. doi:https://doi.org/10.1358/dnp.2010.23.7.1484488.
- Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–18. doi:https://doi.org/10.1136/bjophthalmol-2011-300539.
- Gupta BM, Bala A, Kshitig A. World cataract research: A scientometric analysis of publications output during 2002-11. Lib Philos Pract. 2013;895:1–17.
- Pollreisz A, Schmidt-Erfurth U. Diabetic cataract& pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:8. doi:https://doi.org/10.1155/2010/608751.
- Yu X, Lyu D, Dong X, He J, Yao K. Hypertension and risk of cataract: a meta-analysis. PLoS One. 2014;9(12):e114012. doi:https://doi.org/10.1371/journal.pone.0114012.
- Choudhary R, Bodakhe SH. Magnesium taurate prevents cataractogenesis via restoration of lenticular oxidative damage and ATPase function in cadmium chloride-induced hypertensive experimental animals. Biomed Pharmacother. 2016;84:836–44. doi:https://doi.org/10.1016/j.biopha.2016.10.012.
- Choudhary R, Bodakhe SH. Olmesartan, an angiotensin II receptor blocker inhibits the progression of cataract formation in cadmium chloride induced hypertensive albino rats. Life Sci. 2016;167:105–12. doi:https://doi.org/10.1016/j.lfs.2016.10.012.
- Khan SA, Choudhary R, Singh A, Bodakhe SH. Hypertension potentiates cataractogenesis in rat eye through modulation of oxidative stress and electrolyte homeostasis. J Curr Ophthalmol. 2016;28(3):123–30. doi:https://doi.org/10.1016/j.joco.2016.05.001.
- Ornek K, Karel F, Buyukbingol Z. May nitric oxide molecule have a role in the pathogenesis of human cataract? Exp Eye Res. 2003;76:23–27.
- Paik DC, Dillon J. The Nitrite/alpha crystallin reaction: a possible mechanism in lens matrix damage. Exp Eye Res. 2000;70(1):73–80. doi:https://doi.org/10.1006/exer.1999.0761.
- Inomata M, Hayashi M, Shumiya S, Kawashima S, Ito Y. Aminoguanidine-treatment results in the inhibition of lens opacification and calpain-mediated proteolysis in Shumiya cataract rats (SCR). J Biochem. 2000;128:771–76.
- Ito Y, Nabekura T, Takeda M, Nakao M, Terao M, Hori R, Tomohiro M. Nitric oxide participates in cataract development in selenite-treated rats. Curr Eye Res. 2001;22:215–20.
- Nabekura T, Koizumi Y, Nakao M, Tomohiro M, Inomata M, Ito Y. Delay of cataract development in hereditary cataract UPL rats by disulfiram and aminoguanidine. Exp Eye Res. 2003;76:169–74.
- El-Gharabawy RM, Ahmed AS, Al-Najjar AH. Cataract induction by administration of nitroglycerin in cardiac patients through imbalance in redox status. Ther Clin Risk Manag. 2016;12:1487–96. doi:https://doi.org/10.2147/TCRM.S114469.
- Balaraman R, Gulati OD, Bhatt JD, Rathod SP, Hemavathi KG. Cadmium-induced hypertension in rats. Pharmacology. 1989;38(4):226–34. doi:https://doi.org/10.1159/000138541.
- Rosales MA, Silva KC, Duarte DA, De Oliveira MG, De Souza GF, Catharino RR, Ferreira MS, Lopes De Faria JB, Lopes De Faria JM. S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci. 2014;55(5):2921–32. doi:https://doi.org/10.1167/iovs.13-13762.
- Giuffrida S, Bucolo C, Drago F. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma. J Ocul Pharmacol Ther. 2003;19(6):527–34. doi:https://doi.org/10.1089/108076803322660440.
- Khan SB, Choudhary R, Vishwakarma PK, Singh A, Shree J, Bodakhe SH. Protective effect of alpha-lipoic acid on progression of cataract formation in fructose-induced experimental cataract. PharmaNutrition. 2017;5(4):127–32. doi:https://doi.org/10.1016/j.phanu.2017.10.001.
- Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47:389–94.
- Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21:130–32.
- Tappel AL. Glutathione peroxidase and hydroperoxides. Methods Enzymol. 1978;52:506–13.
- Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77.
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–58.
- Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131–38.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.
- Manikandan R, Thiagarajan R, Beulaja S, Sudhandiran G, Arumugam M. Curcumin prevents free radical-mediated cataractogenesis through modulations in lens calcium. Free Radic Biol Med. 2010;48(4):483–92. doi:https://doi.org/10.1016/j.freeradbiomed.2009.11.011.
- Sai Varsha MK, Raman T, Manikandan R. Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasis. Exp Eye Res. 2014;128:73–82. doi:https://doi.org/10.1016/j.exer.2014.09.007.
- Schaumberg DA, Glynn RJ, Christen WG, Ajani UA, Sturmer T, Hennekens CH. A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol. 2001;11:104–10.
- Singh A, Khan SA, Choudhary R, Bodakhe SH. Cinnamaldehyde attenuates cataractogenesis via restoration of hypertension and oxidative stress in fructose-fed hypertensive rats. J Pharmacopuncture. 2016;19(2):137–44. doi:https://doi.org/10.3831/KPI.2016.19.015.
- Sangartit W, Kukongviriyapan U, Donpunha W, Pakdeechote P, Kukongviriyapan V, Surawattanawan P, Greenwald SE, Gupta S. Tetrahydrocurcumin protects against cadmium-Induced hypertension, raised arterial stiffness and vascular remodeling in mice. PLoS One. 2014;9(12):e114908. doi:https://doi.org/10.1371/journal.pone.0114908.
- Nwokocha CR, Baker A, Douglas D, McCalla G, Nwokocha M, Brown PD. Apocynin ameliorates cadmium-induced hypertension through elevation of endothelium nitric oxide synthase. Cardiovasc Toxicol. 2013;13(4):357–63. doi:https://doi.org/10.1007/s12012-013-9216-0.
- Rathod S, Shah N, Balaraman R. Antihypertensive effect of dietary calcium and diltiazem, a calcium channel blocker on experimentally induced hypertensive rats. Indian J Pharmacol. 1997;29:99–104.
- Ahmed MA. Effect of angiotensin II type 1 receptor blocker on renal function, arterial blood pressure and parathyroid hormone related protein over expression in cadmium induced nephrotoxicity in adult male rats. Int J Physiol Pathophysiol Pharmacol. 2013;5:109–19.
- Chou TC, Yang SP, Pei D. Amlodipine inhibits pro-inflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide/interferon-gamma-stimulated cultured vascular smooth muscle cells. Jpn J Pharmacol. 2002;89:157–63.
- Wang WZ, Matsumori A, Yamada T, Shioi T, Okada I, Matsui S, Sato Y, Suzuki H, Shiota K, Sasayama S. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Circulation. 1997;95:245–51.
- Briones AM, Alonso MJ, Marin J, Balfagon G, Salaices M. Influence of hypertension on nitric oxide synthase expression and vascular effects of lipopolysaccharide in rat mesenteric arteries. Br J Pharmacol. 2000;131(2):185–94. doi:https://doi.org/10.1038/sj.bjp.0703552.
- Smith CJ, Santhanam L, Bruning RS, Stanhewicz A, Berkowitz DE, Holowatz LA. Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension (Dallas, Tex: 1979). 2011;58(5):935–42. doi:https://doi.org/10.1161/HYPERTENSIONAHA.111.178129.
- Zhang R, Yi R, Bi Y, Xing L, Bao J, Li J. The effect of selenium on the Cd-induced apoptosis via NO-mediated mitochondrial apoptosis pathway in chicken liver. Biol Trace Elem Res. 2017;178(2):310–19. doi:https://doi.org/10.1007/s12011-016-0925-7.
- Wei T, Chen C, Hou J, Xin W, Mori A. Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim Biophys Acta. 2000;1498:72–79.
- Klatt P, Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem. 2000;267:4928–44.
- Andjelic S, Hawlina M. Cataractogenesis. Zdrav Vestn. 2012;81:I122–132.
- Boscia F, Grattagliano I, Vendemiale G, Micelli-Ferrari T, Altomare E. Protein oxidation and lens opacity in humans. Invest Ophthalmol Vis Sci. 2000;41:2461–65.
- Shearer TR, David LL, Anderson RS. Selenite cataract: a review. Curr Eye Res. 1987;6:289–300.
- Benedetti A, Fulceri R, Comporti M. Inhibition of calcium sequestration activity of liver microsomes by 4-hydroxyalkenals originating from the peroxidation of liver microsomal lipids. Biochimica Et Biophysica Acta (BBA) - Lipids Lipid Metab. 1984;793(3):489–93. doi:https://doi.org/10.1016/0005-2760(84)90268-6.
- Nagai N, Ito Y, Takeuchi N. Inhibitive effects of enhanced lipid peroxidation on Ca2+-ATPase in lenses of hereditary cataract ICR/f rats. Toxicology. 2008;247(2):139–44. doi:https://doi.org/10.1016/j.tox.2008.02.016.
- Ellis DZ, Nathanson JA, Rabe J, Sweadner KJ. Carbachol and nitric oxide inhibition of Na,K-ATPase activity in bovine ciliary processes. Invest Ophthalmol Vis Sci. 2001;42:2625–31.
- Shahidullah M, Mandal A, Wei G, Delamere NA. Nitric oxide regulation of Na, K-ATPase activity in ocular ciliary epithelium involves Src family kinase. J Cell Physiol. 2014;229(3):343–52. doi:https://doi.org/10.1002/jcp.24454.
- Eriyamremu GE, Ojimogho SE, Asagba SO, Osagie VE. Palm oil induced changes in ocular tissue lipid peroxidation, antioxidant enzymes and ATPases of rabbits in cadmium toxicity. Food Chem Toxicol. 2008;46(9):3155–58. doi:https://doi.org/10.1016/j.fct.2008.06.088.
- Mathias RT, White TW, Gong X. Lens gap junctions in growth, differentiation, and homeostasis. Physiol Rev. 2010;90(1):179–206. doi:https://doi.org/10.1152/physrev.00034.2009.
- Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond B Biol Sci. 2011;366(1568):1278–92. doi:https://doi.org/10.1098/rstb.2010.0300.
- Gupta PD, Johar K, Vasavada A. Causative and preventive action of calcium in cataracto-genesis. Acta Pharmacol Sin. 2004;25:1250–56.
- Huang P, Jiang Z, Teng S, Wong YC, Frohman MA, Chung SK, Chung SSM. Synergism between phospholipase D2 and sorbitol accumulation in diabetic cataract formation through modulation of Na,K-ATPase activity and osmotic stress. Exp Eye Res. 2006;83(4):939–48. doi:https://doi.org/10.1016/j.exer.2006.05.001.